Report Detail

Other Global Oncolytic Virus Immunotherapy Market Size, Status and Forecast 2019-2025

  • RnM3411444
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 pages
  • |
  • QYResearch
  • |
  • Other

Global Oncolytic Virus Immunotherapy Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Engineering Oncolytic Viruses
      • 1.4.3 Wild-Type Oncolytic Viruses
    • 1.5 Market by Application
      • 1.5.1 Global Oncolytic Virus Immunotherapy Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Ambulatory Surgical Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Oncolytic Virus Immunotherapy Market Size
    • 2.2 Oncolytic Virus Immunotherapy Growth Trends by Regions
      • 2.2.1 Oncolytic Virus Immunotherapy Market Size by Regions (2014-2025)
      • 2.2.2 Oncolytic Virus Immunotherapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Oncolytic Virus Immunotherapy Market Size by Manufacturers
      • 3.1.1 Global Oncolytic Virus Immunotherapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
    • 3.3 Key Players Oncolytic Virus Immunotherapy Product/Solution/Service
    • 3.4 Date of Enter into Oncolytic Virus Immunotherapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Oncolytic Virus Immunotherapy Market Size by Type (2014-2019)
    • 4.2 Global Oncolytic Virus Immunotherapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Oncolytic Virus Immunotherapy Market Size (2014-2019)
    • 5.2 Oncolytic Virus Immunotherapy Key Players in United States
    • 5.3 United States Oncolytic Virus Immunotherapy Market Size by Type
    • 5.4 United States Oncolytic Virus Immunotherapy Market Size by Application

    6 Europe

    • 6.1 Europe Oncolytic Virus Immunotherapy Market Size (2014-2019)
    • 6.2 Oncolytic Virus Immunotherapy Key Players in Europe
    • 6.3 Europe Oncolytic Virus Immunotherapy Market Size by Type
    • 6.4 Europe Oncolytic Virus Immunotherapy Market Size by Application

    7 China

    • 7.1 China Oncolytic Virus Immunotherapy Market Size (2014-2019)
    • 7.2 Oncolytic Virus Immunotherapy Key Players in China
    • 7.3 China Oncolytic Virus Immunotherapy Market Size by Type
    • 7.4 China Oncolytic Virus Immunotherapy Market Size by Application

    8 Japan

    • 8.1 Japan Oncolytic Virus Immunotherapy Market Size (2014-2019)
    • 8.2 Oncolytic Virus Immunotherapy Key Players in Japan
    • 8.3 Japan Oncolytic Virus Immunotherapy Market Size by Type
    • 8.4 Japan Oncolytic Virus Immunotherapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Oncolytic Virus Immunotherapy Market Size (2014-2019)
    • 9.2 Oncolytic Virus Immunotherapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type
    • 9.4 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application

    10 India

    • 10.1 India Oncolytic Virus Immunotherapy Market Size (2014-2019)
    • 10.2 Oncolytic Virus Immunotherapy Key Players in India
    • 10.3 India Oncolytic Virus Immunotherapy Market Size by Type
    • 10.4 India Oncolytic Virus Immunotherapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Oncolytic Virus Immunotherapy Market Size (2014-2019)
    • 11.2 Oncolytic Virus Immunotherapy Key Players in Central & South America
    • 11.3 Central & South America Oncolytic Virus Immunotherapy Market Size by Type
    • 11.4 Central & South America Oncolytic Virus Immunotherapy Market Size by Application

    12 International Players Profiles

    • 12.1 Merck
      • 12.1.1 Merck Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Oncolytic Virus Immunotherapy Introduction
      • 12.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
      • 12.1.5 Merck Recent Development
    • 12.2 Amgen
      • 12.2.1 Amgen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Oncolytic Virus Immunotherapy Introduction
      • 12.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
      • 12.2.5 Amgen Recent Development
    • 12.3 TILT Biotherapeutics
      • 12.3.1 TILT Biotherapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Oncolytic Virus Immunotherapy Introduction
      • 12.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
      • 12.3.5 TILT Biotherapeutics Recent Development
    • 12.4 Oncorus
      • 12.4.1 Oncorus Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Oncolytic Virus Immunotherapy Introduction
      • 12.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
      • 12.4.5 Oncorus Recent Development
    • 12.5 Sorrento Therapeutics
      • 12.5.1 Sorrento Therapeutics Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Oncolytic Virus Immunotherapy Introduction
      • 12.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
      • 12.5.5 Sorrento Therapeutics Recent Development
    • 12.6 Shanghai Sunway Biotech
      • 12.6.1 Shanghai Sunway Biotech Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Oncolytic Virus Immunotherapy Introduction
      • 12.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2014-2019)
      • 12.6.5 Shanghai Sunway Biotech Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
      North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
      In 2018, the global Oncolytic Virus Immunotherapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Oncolytic Virus Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncolytic Virus Immunotherapy development in United States, Europe and China.

      The key players covered in this study
      Merck
      Amgen
      TILT Biotherapeutics
      Oncorus
      Sorrento Therapeutics
      Shanghai Sunway Biotech
      ...

      Market segment by Type, the product can be split into
      Engineering Oncolytic Viruses
      Wild-Type Oncolytic Viruses

      Market segment by Application, split into
      Hospitals
      Clinics
      Ambulatory Surgical Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Oncolytic Virus Immunotherapy status, future forecast, growth opportunity, key market and key players.
      To present the Oncolytic Virus Immunotherapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Oncolytic Virus Immunotherapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Oncolytic Virus Immunotherapy. Industry analysis & Market Report on Oncolytic Virus Immunotherapy is a syndicated market report, published as Global Oncolytic Virus Immunotherapy Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Oncolytic Virus Immunotherapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,125.01
      4,687.52
      6,250.02
      3,471.71
      5,207.56
      6,943.42
      420,365.40
      630,548.10
      840,730.80
      268,573.11
      402,859.67
      537,146.22
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report